SCHEMBL4592658

SCHEMBL4592658

FC(F)(F)c1ccc2c(OCCCCCBr)ccnc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAK O14976 3/20 0.43
NCF1 P14598 2/20 0.41
ADRB2 P07550 1/20 0.41
RAC1 P63000 2/20 0.41
RAC2 P15153 1/20 0.41
RAC3 P60763 1/20 0.41
PARP1 P09874 1/20 0.39
AAK1 Q2M2I8 3/20 0.38
GRM4 Q14833 1/20 0.37
PRKD3 O94806 2/20 0.37
MAP4K4 O95819 2/20 0.37
KDR P35968 2/20 0.37
GSK3A P49840 2/20 0.37
GSK3B P49841 2/20 0.37
AURKB Q96GD4 2/20 0.37
PRKD2 Q9BZL6 2/20 0.37
CLK4 Q9HAZ1 2/20 0.37
PLK4 O00444 1/20 0.37
DYRK3 O43781 1/20 0.37
CHEK2 O96017 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25403151 1.00 GAK (0.43) GAKNCF1ADRB2RAC1RAC2
SCHEMBL1461737 0.85 GAK (0.46) GAKNCF1ADRB2RAC1RAC2
SCHEMBL12968479 0.84 GAK (0.47) GAKNCF1ADRB2RAC1RAC2
SCHEMBL15473239 0.82 GAK (0.48) GAKNCF1ADRB2PARP1AAK1
SCHEMBL22809487 0.82 GAK (0.45) GAKNCF1ADRB2RAC1RAC2
SCHEMBL4419956 0.82 GAK (0.45) GAKNCF1ADRB2RAC1RAC2
SCHEMBL4150418 0.80 LMNA (0.48)
SCHEMBL7503944 0.78 CYP11B1 (0.58) GAKNCF1ADRB2PARP1GRM4
SCHEMBL2797692 0.77 GAK (0.64) GAKNCF1ADRB2PARP1AAK1
SCHEMBL4146513 0.77 RAC1 (0.54) GAKNCF1ADRB2RAC1RAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910334-A2 COMPOUNDS AND METHODS FOR TREATMENT OF AMYLOID-BETA-PEPTIDE RELATED DISORDERS Exonhit Therapeutics SA (FR) 2008-04-16 EP disclosed
WO-2007034329-A2 COMPOUNDS AND METHODS FOR TREATMENT OF AMYLOID-BETA-PEPTIDE RELATED DISORDERS EXONHIT THERAPEUTICS SA (FR) 2007-03-29 WO disclosed